Modelled over 5 years at typical UK 5 mg Mounjaro pricing: About 3,700 with a structured programme over 15 months
These results have positioned obesity drugs as cornerstone treatments for both metabolic and cardiovascular health, marking a new phase of market maturity
To view or add a comment, sign in #GLP1 medicines now address weight loss and other health conditions through innovative formulations and expanded indications, highlighting key questions about their efficacy and safety
That makes it a strong option for laboratories focused on pathway mapping, structured signaling models, and metabolic system analysis with a narrower research lens
Lipid improvements Retatrutide produces substantial improvements in lipid profiles
This development has led to the introduction of several GLP-1 receptor agonists and DPP-4 inhibitors on the market [3], which are featured prominently in current recommendations because of their effectiveness, safety and proven cardiovascular benefits [33]